METHOD OF RECOMBINANT HUMAN INSULIN PREPARING
FIELD: biotechnology, preparative biochemistry, endocrinology. SUBSTANCE: the strain-producer E. coli JM109/pPINS07 is cultured, cells are disrupted by disintegration, inclusion bodies containing the fused protein are dissolved in a buffer containing urea and dithiothreitol, renaturated and the fuse...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: biotechnology, preparative biochemistry, endocrinology. SUBSTANCE: the strain-producer E. coli JM109/pPINS07 is cultured, cells are disrupted by disintegration, inclusion bodies containing the fused protein are dissolved in a buffer containing urea and dithiothreitol, renaturated and the fused protein is purified by precipitation of inert compounds in 40% isopropyl alcohol followed by chromatography on CM-Sepharose. Then the fused protein is cleaved by trypsin, products of trypsinolysis are subjected for chromatography on SP-Sepharose using the gradient linear elution with sodium chloride at concentration from 0 to 0.5 M prepared on the initial buffer followed by hydrolysis with carboxypeptidase B. Obtained insulin fraction is purified by method of high-effective liquid chromatography with reversed phase and the following gel-filtration. Method ensures to obtain insulin of the improved quality at purity 96%, not less, and activity 26 U/mg, not less. Method can be used in the industrial scale. EFFECT: improved method of preparing, high purity and activity, availability and safety of sorbents. 1 tbl, 1 ex |
---|